drugset / Trial / NCT00814736
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
RandomizedCrossoverDouble-blindBasic science
Summary
To investigate the safety and overall tolerability of co-administration two PDE5 inhibitors UK369,003 and sildenafil
Timeline
- Start
- 2008-08
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GISADENAFIL | Small molecule | 100 mg | Oral |
| Subject | Sildenafil | Unknown | 100 mg | Oral |